RGDfV increases ASM mRNA, ASM activity and ceramide levels and decreases sphingomyelins. by Xiuhai Ren (312555)

RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression. by Xiaojuan Li (351842)

Decrease of NF-κB activity in tumor tissue of CCR5^−/− mice. by Ju Kyoung Song (324058)

“…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5^−/− mice and CCR5^+/+ mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”

Decreased diaphragm muscle lateral bifurcations in GAD67-deficient (−/−) E15.5 mice. by Matthew J. Fogarty (283288)

“…<b>D</b> shows a significantly decreased lateral bifurcation number but not medial bifurcation (mean ± SEM) in GAD67-deficient mice compared to wild type (<i>n</i> = 5, *<i>P</i><0.05, unpaired <i>t</i> test). …”

Effect of lysosomal hydrolysis inhibition on the decrease of PrP^Sc levels induced by CPZ or U18666A treatment. by Takeshi Yamasaki (521196)

Regulation of skin γδ T cell proliferation by glucose is associated with decreased STAT5B phosphorylation. by Kristen R. Taylor (246328)

Hypoxia decreases expression of AQP5 protein and mRNA levels in MLE-12 cells. by Jitesh D. Kawedia (384551)

FABP5 down regulation increases inflammation but decreases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

“…<p><b>A.</b> CS exposure increases <i>P. aeruginosa</i> colony forming units (CFU) on FABP5 knocked down primary NHBE cells. …”

<i>Tnks</i> DKO leads to decreased Wnt/β-catenin signaling activity. by Pan Ye (2902336)

si-AGR2 decreased DNP-mediated invasion and motility in 5–8F cells. by Yuejin Li (410414)

Metformin decreases ATP levels in medium containing low glucose (2.5 mM). by Yongxian Zhuang (634693)

Deletion of <i>VdSep5</i> decreased secretory protein delivery to the hyphal neck. by Ting-Ting Zhou (2236807)

Disruption of putative host factor LGMN decreases SARS-CoV-2 viral entry. by Ravi K. Dinesh (21736629)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”

TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

Decreased tumorigenicity of Daoy cells over-expressing miR-199b-5p. by Livia Garzia (266719)

Rabankyrin-5 Overexpression Increases, whereas Knock-Down Decreases Fluid-Phase Uptake, Specifically by Carsten Schnatwinkel (48)

Expression of human PON1 decreases superoxide levels in <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Mean (± standard error) of deermouse visits to the foraging stations and mean (± standard error) number of intra- and interspecific interactions of deermice (DM) among treatments (... by André V. Rubio (4594702)

<i>mbtK</i> deletion decreases phospholipid abundance during iron starvation. by Cressida A. Madigan (713924)